Daniel Camardo
Direktor/Vorstandsmitglied bei CommunityHealth NFP
Vermögen: 1 141 $ am 30.04.2024
Aktive Positionen von Daniel Camardo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CommunityHealth NFP | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Daniel Camardo
Ehemalige bekannte Positionen von Daniel Camardo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ATHERSYS, INC. | Comptroller/Controller/Auditor | 02.07.2022 | 31.12.2023 |
| Direktor/Vorstandsmitglied | 14.02.2022 | 31.12.2023 | |
| Vorstandsvorsitzender | 14.02.2022 | 31.12.2023 | |
| Finanzdirektor/CFO | 02.07.2022 | - | |
| Unternehmenssekretär | 14.02.2022 | 31.12.2023 | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01.09.2015 | 01.02.2022 |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Vertrieb & Marketing | 01.07.2014 | 01.09.2015 |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Corporate Officer/Principal | 01.01.2003 | 01.01.2004 |
Ausbildung von Daniel Camardo
| Rochester Christian University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 7 |
| Irland | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ATHERSYS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Health Technology |
| CommunityHealth NFP |
- Börse
- Insiders
- Daniel Camardo
- Erfahrung
